Combination of PI3K/mTOR inhibitors: antitumor activity and molecular correlates. [electronic resource]
Producer: 20110929Description: 4573-84 p. digitalISSN:- 1538-7445
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Cell Line, Tumor
- Drug Administration Schedule
- Drug Synergism
- Female
- Furans -- administration & dosage
- Humans
- Male
- Mechanistic Target of Rapamycin Complex 1
- Mice
- Mice, Nude
- Multiprotein Complexes
- Phosphoinositide-3 Kinase Inhibitors
- Protein Kinase Inhibitors -- pharmacology
- Proteins -- antagonists & inhibitors
- Proto-Oncogene Proteins c-akt -- metabolism
- Pyridines -- administration & dosage
- Pyrimidines -- administration & dosage
- Sirolimus -- administration & dosage
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.